Article Details


Sanyogita Haralea *, Pooja Huparea , Prajakta Ghatagea , Vijaya Govandea , Omkar Gurava , Sandip Bandgara , Sachin Patila and Dinanath Gaikwadb

a Department of Pharmaceutics, Ashokrao Mane College of Pharmacy, Peth-Vadgaon – 416 112, Maharashtra, India

b Department of Pharmaceutics, Bharati Vidyapeeth College of Pharmacy, Kolhapur – 416 013, Maharashtra, India

* For Correspondence: E-mail:


The term “drug repurposing” refers to the practice of identifying unmet medical needs and developing innovative solutions using already available drugs. It’s a useful strategy for identifying or developing new medicinal molecules with untapped therapeutic potential. Some of the computational drugs repurposing methods currently in use have been employed in the fight against the 2019 coronavirus illness (COVID-19) pandemic. Many currently used medications are being repurposed, thanks to advances in computational approaches and a fundamental understanding of viral etiology and pharmacological pharmacodynamics. The objective of this work is to highlight the utilization of repurposed medicines for COVID-19, bacterial infections and cancer therapy. The drug repurposing method is fast-growing in both business and academia, since it focuses on the initial knowledge and investment that brought the product to market in the first place. Recently, medication repositioning has been included in the drug R&D plans of several pharmaceutical companies, aiming to create new therapies in response to the identification of novel biological targets. In addition to being highly efficient, the drug repurposing method also saves money and the pharmacological profiles are generally known.

Year 2023 | Volume No. 60 | Issue No.11 | Page No. 7-18
Recent Issue
Current Issue
May 2024
Quick Contact